UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2021-06, Vol.15 (6), p.879-913

2021

Volltextzugriff (PDF)

Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat

Gastroenterology (New York, N.Y. 1943), 1999-11, Vol.117 (5), p.1222-1228

1999

Volltextzugriff (PDF)

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

Alimentary Pharmacology & Therapeutics (Suppl), 2013-11, Vol.38 (9), p.1109-1118

2013

Volltextzugriff (PDF)

Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron‐containing medicines

Alimentary Pharmacology & Therapeutics (Suppl), 2014-04, Vol.39 (7), p.743-744

2014

Volltextzugriff (PDF)

European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

Journal of Crohn's and colitis, 2023-01, Vol.17 (1), p.1-27

2023

Volltextzugriff (PDF)

P401 Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn’s Disease but not in Ulcerative Colitis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i531-i532

2023

Volltextzugriff (PDF)

P618 Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn's Disease patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1191-i1191

2024

Volltextzugriff (PDF)

P703 Comparison of infliximab and adalimumab therapies Persistence in patients with Ulcerative Colitis: Results from a Single Tertiary Turkish IBD Center Cohort

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1328-i1328

2024

Volltextzugriff (PDF)

P920 Efficacy and Drug Adherence Rates of Anti TNF Drugs in patients with Crohn's Disease: A Single Tertiary IBD Center Cohort

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1678-i1678

2024

Volltextzugriff (PDF)

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

Journal of viral hepatitis, 2004-03, Vol.11 (2), p.141-147

2004

Volltextzugriff (PDF)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

United European gastroenterology journal, 2022-07, Vol.10 (6), p.556-584

2022

Volltextzugriff (PDF)

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

Journal of viral hepatitis, 2005-05, Vol.12 (3), p.262-268

2005

Volltextzugriff (PDF)

PGI21 - COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN’S DISEASE FOR TURKEY

Value in health, 2018-10, Vol.21, p.S145-S145

2018

Volltextzugriff (PDF)

P1131 Epidemiological Characteristics of Inflammatory Bowel Diseases in The Last Decade: Multi-Center Türkiye Data

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i2025-i2027

2024

Volltextzugriff (PDF)

Current and novel therapeutics in the treatment of systemic lupus erythematosus

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.303-312

2011

Volltextzugriff (PDF)

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Rheumatology international, 2006-05, Vol.26 (7), p.663-668

2006

Volltextzugriff (PDF)

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

Hepatology (Baltimore, Md.), 1998-10, Vol.28 (4), p.926-931

1998

Volltextzugriff (PDF)

P432 Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the ‘EXPLORE’ study

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S324-S325

2019

Volltextzugriff (PDF)

Antianoikis Effect of Nuclear Factor-κB through Up-regulated Expression of Osteoprotegerin, BCL-2, and IAP-1

The Journal of biological chemistry, 2006-03, Vol.281 (13), p.8686-8696

2006

Volltextzugriff (PDF)

AB0715 The Frequency of Spondyloarthropathy in Inflammatory Bowel Diseases

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1040-1040

2014

Volltextzugriff (PDF)

AB0011 Association between Single Nucleotide Polymorphisms (SNPS) in Prospective Genes and Susceptibility to Ankylosing Spondylitis, Inflammatory Bowel Disease in A Turkish Population

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.807-807

2014

Volltextzugriff (PDF)

Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms

Journal of gastroenterology and hepatology, 2004-05, Vol.19 (5), p.535-540

2004

Volltextzugriff (PDF)

Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution

American journal of physiology: Gastrointestinal and liver physiology, 2004-12, Vol.287 (6), p.G1213-G1219

2004

Volltextzugriff (PDF)

Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

Inflammatory bowel diseases, 2005-05, Vol.11 (5), p.428-434

2005

Volltextzugriff (PDF)

P435 Management of iron deficiency in inflammatory bowel disease: results from a RAND/UCLA appropriateness study

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S184-S184

2013

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(147)
Tagungsberichte
(1)

Sprache

Englisch
(147)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron‐containing medicines

European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

P401 Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn’s Disease but not in Ulcerative Colitis

P618 Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn's Disease patients

P703 Comparison of infliximab and adalimumab therapies Persistence in patients with Ulcerative Colitis: Results from a Single Tertiary Turkish IBD Center Cohort

P920 Efficacy and Drug Adherence Rates of Anti TNF Drugs in patients with Crohn's Disease: A Single Tertiary IBD Center Cohort

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

PGI21 - COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN’S DISEASE FOR TURKEY

P1131 Epidemiological Characteristics of Inflammatory Bowel Diseases in The Last Decade: Multi-Center Türkiye Data

Current and novel therapeutics in the treatment of systemic lupus erythematosus

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

P432 Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the ‘EXPLORE’ study

Antianoikis Effect of Nuclear Factor-κB through Up-regulated Expression of Osteoprotegerin, BCL-2, and IAP-1

AB0715 The Frequency of Spondyloarthropathy in Inflammatory Bowel Diseases

AB0011 Association between Single Nucleotide Polymorphisms (SNPS) in Prospective Genes and Susceptibility to Ankylosing Spondylitis, Inflammatory Bowel Disease in A Turkish Population

Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms

Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution

Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

P435 Management of iron deficiency in inflammatory bowel disease: results from a RAND/UCLA appropriateness study

Suchergebnisse filtern